Hyperfine (NASDAQ:HYPR) Coverage Initiated by Analysts at Wells Fargo & Company

Equities research analysts at Wells Fargo & Company assumed coverage on shares of Hyperfine (NASDAQ:HYPRGet Rating) in a report released on Thursday, The Fly reports. The brokerage set an “overweight” rating and a $8.00 price target on the stock. Wells Fargo & Company‘s price target points to a potential upside of 128.57% from the stock’s current price.

Shares of NASDAQ:HYPR opened at $3.50 on Thursday. The firm has a fifty day moving average price of $3.39. Hyperfine has a one year low of $2.45 and a one year high of $16.61.

Large investors have recently made changes to their positions in the business. Monashee Investment Management LLC purchased a new stake in shares of Hyperfine during the 4th quarter valued at $15,743,000. Fosun International Ltd purchased a new stake in shares of Hyperfine during the 4th quarter valued at $12,630,000. Perceptive Advisors LLC purchased a new stake in shares of Hyperfine during the 4th quarter valued at $10,875,000. ARK Investment Management LLC purchased a new stake in shares of Hyperfine during the 4th quarter valued at $7,250,000. Finally, Deerfield Management Company L.P. Series C purchased a new stake in shares of Hyperfine during the 4th quarter valued at $7,250,000. 95.91% of the stock is owned by hedge funds and other institutional investors.

Hyperfine Company Profile (Get Rating)

Hyperfine Inc is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc, formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

Featured Stories

The Fly logo

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.